Metabolic biomarkers of treatment-resistant schizophrenia and cognitive correlates: insights from a machine learning
- 19 August 2026
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- p. 1-10
Abstract
Early identification of Treatment-resistant schizophrenia (TRS) remains a challenge. Metabolomics offers a promising strategy for identifying biomarkers and uncovering the metabolic alterations underlying TRS. Machine learning (ML), increasingly applied in omics research, enables the development of predictive models from complex datasets. This study aimed to develop a metabolomics-based ML model for TRS identification and to examine its association with cognitive impairments. 112 TRS patients, 232 non-TRS patients, and 145 sex- and age-matched healthy controls were recruited in this study. Psychiatric symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), and cognitive function was evaluated with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Toronto Alexithymia Scale (TAS-26). Fasting blood samples were collected from all participants and analyzed by UHPLC-HRMS, enabling the quantification and profiling of 699 metabolites. The resulting data were then subjected to orthogonal partial least squares discriminant analysis (OPLS-DA), and a predictive model was constructed using a random forest algorithm, which was validated through 5 × 5 nested cross-validation with inner-loop LASSO feature selection. From 699 metabolites, 58 metabolites exhibited significant changes (VIP > 1.5, FDR p < 0.05). 5 × 5 nested cross-validation combining an inner-loop LASSO feature selection model yielded a pooled out-of-fold AUC of 0.958 (95% CI (DeLong): 0.940–0.977) for TRS classification. Further correlation analyses revealed distinct associations between the top five predictive metabolites and cognitive domains in TRS versus non-TRS patients. Gamma-glutamylthreonine (gamma-Glu-Thr) showed a significant negative correlation with visuospatial cognition in TRS patients (r = −0.25, p = 0.009). In contrast, it showed a positive correlation in the non-TRS group (r = 0.16, p = 0.015). However, these associations did not remain significant after FDR correction. This study established an RF-metabolomic model for identifying TRS and provided specific metabolic signatures associated with cognitive dysfunction.Keywords
Funding Information
- Tianjin Municipal Education Commission Scientific Research Program Project
This publication has 50 references indexed in Scilit:
- Sex differences in plasma lipid profiles, but not in glucose metabolism in patients with first-episode antipsychotics-naïve schizophreniaBrain Research, 2024
- Factors associated with cognitive dysfunction in treatment-responsive and -resistant schizophrenia: A pilot cross-sectional studyJournal of Psychiatric Research, 2024
- Deconstructing the genetic architecture of treatment-resistant schizophrenia in East Asian ancestryAsian Journal of Psychiatry, 2023
- Emotion, motivation, decision-making, the orbitofrontal cortex, anterior cingulate cortex, and the amygdalaBrain Structure and Function, 2023
- Integrated untargeted fecal metabolomics and gut microbiota strategy for screening potential biomarkers associated with schizophreniaJournal of Psychiatric Research, 2022
- Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approachJournal of Psychiatric Research, 2022
- Serum kynurenine metabolites might not be associated with risk factors of treatment-resistant schizophreniaJournal of Psychiatric Research, 2022
- Neuropeptides and oligopeptidases in schizophreniaNeuroscience & Biobehavioral Reviews, 2020
- Subchronic ketamine alters behaviour, metabolic indices and brain morphology in adolescent rats: Involvement of oxidative stress, glutamate toxicity and caspase-3-mediated apoptosisJournal of Chemical Neuroanatomy, 2019
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009